Prognostic parameters in recurrent malignant melanoma

In 361 patients with recurrent malignant melanoma, the clinical stage was the strongest determinant of subsequent survival (P < 0.01). In Stage IV, the number of initial, distinct lesions was important. Patients presenting with a single metastatic nodule had median survival ten months, whereas th...

Full description

Saved in:
Bibliographic Details
Published in:Cancer 1983-08, Vol.52 (3), p.575-579
Main Authors: Karakousis, C. P., Temple, D. F., Moore, R., Ambrus, J. L.
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
Child
Child, Preschool
Female
Humans
Male
Melanoma - pathology
Melanoma - surgery
Middle Aged
Neoplasm Metastasis
Neoplasm Recurrence, Local
Prognosis
Skin Neoplasms - pathology
Skin Neoplasms - surgery
Time Factors
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In 361 patients with recurrent malignant melanoma, the clinical stage was the strongest determinant of subsequent survival (P < 0.01). In Stage IV, the number of initial, distinct lesions was important. Patients presenting with a single metastatic nodule had median survival ten months, whereas those with two or more metastatic nodules had median survival 6.9 months (P < 0.05). The length of disease‐free interval from excision of the primary to recurrence correlated consistently with subsequent survival in patients with regional lymph node metastases. Those with disease‐free interval less than one year had median survival 15.8 months with 16% surviving at five years, while those with interval one year or longer had median survival 23.7 months with 30% surviving at five years (P < 0.05). In Stage IV, the correlation of survival with disease‐free interval became significant only with 24 months as the demarcation point of length of disease‐free interval. Age and sex affected the disease‐free interval, but not survival after recurrence.
ISSN:0008-543X
1097-0142
DOI:10.1002/1097-0142(19830801)52:3<575::AID-CNCR2820520333>3.0.CO;2-6